| Name | Title | Contact Details |
|---|
Matousek and Associates is a Green Bay, WI-based company in the Business Services sector.
Technology advancements in lighting, especially LED, are creating tremendous opportunities in the field of light. Lighting solutions today not only need to work and to last, they need to give customers a competitive edge. Companies developing automotive, mobile, IoT and illumination lighting applications require a partner who can collaborate with them to push the boundaries of light. With more than 100 years of inventions and industry firsts, Lumileds is a global lighting solutions company that helps customers around the world deliver differentiated solutions to gain and maintain a competitive edge. As the inventor of Xenon technology, a pioneer in halogen lighting and the leader in high performance LEDs, Lumileds builds innovation into everything it does. Whats more, quality and reliability are guiding principles for Lumileds. The company demonstrates this by maintaining control over materials, processes and technologies and by helping customers engineer the best quality of light for their application to achieve the highest levels of performance. The best innovation happens when great minds work together. Lumileds acts with integrity as a trusted partner to its customers, honoring commitments, offering deep expertise, and going the extra mile — making the world better, safer, more beautiful — with light.
Haven Home Care is a Uniontown, OH-based company in the Business Services sector.
CARB-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator) is a global non-profit partnership dedicated to accelerating early development antibacterial R&D to address the rising global threat of drug-resistant bacteria. CARB-X is led by Boston University and its funding is provided by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services; the Wellcome Trust, a global charity based in the UK; Germanys Federal Ministry of Education and Research (BMBF); the UK Department of Health and Social Cares Global Antimicrobial Resistance Innovation Fund (UK GAMRIF); the Bill & Melinda Gates Foundation, and with in-kind support from National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health (NIH) within the HHS. CARB-X is investing more than $500 million from 2016-2021 to support innovative antibiotics and other therapeutics, vaccines and rapid diagnostics. CARB-X supports the worlds largest and most innovative pipeline of preclinical products against drug-resistant infections. CARB-X focuses exclusively on high priority drug-resistant bacteria, especially Gram-negatives. CARB-X is headquartered at Boston University School of Law.
amoebalabs is a Brooklyn, NY-based company in the Business Services sector.